“HHS should consider using march-in rights when drugs face limited competition or market practices have failed to ensure an affordable price, ensuring that prescription drugs invented with taxpayer dollars are reasonably priced and affordable.”
Elizabeth Warren
Senator (D-Mass.). in a letter written to Health and Human Services Secretary Xavier Becerra. Claim dated 28 Jul 2021.
Washington Post rated thisLacks context
What Washington Post found
This remains a theory. No administration or court has ever accepted this reasoning.
Their words, from the summary they publish with the rating.
Where the claim appeared
- warren.senate.govhttps://www.warren.senate.gov/imo/media/doc/2021.07.28%20Letter%20to%20Secretary%20Becerr…
Links recorded by Washington Post. Some posts may have been deleted since.
This check was done by Washington Post, not by DoesItStand. We list it so you can find it. Their full evidence and reasoning are in their article.